Growth Metrics

Bio-Techne (TECH) Non-Current Assets (2009 - 2026)

Bio-Techne's quarterly Non-Current Assets came in at $1.9 billion in Q1 2026, down 7.66% year-on-year from $2.0 billion in Q1 2025, and down 1.2% quarter-over-quarter from $1.9 billion in Q4 2025.

Bio-Techne has reported Non-Current Assets for 18 years, with the latest figure at $1.9 billion in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets fell 7.66% year-over-year to $1.9 billion; the trailing twelve-month figure through Mar 2026 stood at $7.7 billion (down 6.9% YoY), and the FY2025 full-year result was $245.7 million, down 2.16% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $1.9 billion, down from $1.9 billion in the prior quarter.
  • The five-year high for Non-Current Assets was $2.2 billion in Q3 2023, with the low at $223.2 million in Q2 2022.
  • Average Non-Current Assets over 5 years is $1.6 billion, with a median of $1.9 billion recorded in 2025.
  • Year-over-year, Non-Current Assets increased 20.3% in 2023 and dropped 8.18% in 2025.
  • Tracing TECH's Non-Current Assets over 5 years: stood at $1.8 billion in 2022, then gained by 19.01% to $2.1 billion in 2023, then dropped by 4.87% to $2.0 billion in 2024, then declined by 7.39% to $1.9 billion in 2025, then dropped by 1.2% to $1.9 billion in 2026.
  • The last three Non-Current Assets figures came in at $1.9 billion (Q1 2026), $1.9 billion (Q4 2025), and $1.9 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 4.56 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 62,953.78
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 486.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 5.83 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.75 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 22.66 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 910.24 Mn
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn 1.86 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.86 Bn
Dec 31, 2025 1.89 Bn
Sep 30, 2025 1.92 Bn
Jun 30, 2025 245.72 Mn
Mar 31, 2025 2.02 Bn
Dec 31, 2024 2.04 Bn
Sep 30, 2024 2.09 Bn
Jun 30, 2024 251.15 Mn
Mar 31, 2024 2.11 Bn
Dec 31, 2023 2.14 Bn
Sep 30, 2023 2.16 Bn
Jun 30, 2023 226.20 Mn
Mar 31, 2023 2.03 Bn
Dec 31, 2022 1.80 Bn
Sep 30, 2022 1.80 Bn
Jun 30, 2022 223.24 Mn
Mar 31, 2022 1.71 Bn
Dec 31, 2021 1.71 Bn
Sep 30, 2021 1.73 Bn
Jun 30, 2021 207.91 Mn
Mar 31, 2021 1.52 Bn
Dec 31, 2020 1.53 Bn
Sep 30, 2020 1.51 Bn
Jun 30, 2020 176.83 Mn
Mar 31, 2020 1.51 Bn
Dec 31, 2019 1.53 Bn
Sep 30, 2019 1.53 Bn
Jun 30, 2019 154.04 Mn
Mar 31, 2019 1.45 Bn
Dec 31, 2018 1.46 Bn
Sep 30, 2018 1.49 Bn
Jun 30, 2018 145.35 Mn
Mar 31, 2018 1.22 Bn
Dec 31, 2017 1.21 Bn
Sep 30, 2017 1.22 Bn
Jun 30, 2017 135.12 Mn
Mar 31, 2017 1.23 Bn
Dec 31, 2016 1.23 Bn
Sep 30, 2016 1.21 Bn
Jun 30, 2016 132.36 Mn
Mar 31, 2016 885.19 Mn
Dec 31, 2015 875.07 Mn
Sep 30, 2015 887.32 Mn
Jun 30, 2015 129.75 Mn
Mar 31, 2015 809.57 Mn
Dec 31, 2014 845.47 Mn
Sep 30, 2014 750.15 Mn
Jun 30, 2014 118.81 Mn
Mar 31, 2014 511.04 Mn
Dec 31, 2013 523.02 Mn
Sep 30, 2013 498.65 Mn
Jun 30, 2013 110.79 Mn
Mar 31, 2013 370.13 Mn
Dec 31, 2012 364.84 Mn
Sep 30, 2012 362.49 Mn
Jun 30, 2012 95.64 Mn
Mar 31, 2012 377.76 Mn
Dec 31, 2011 397.03 Mn
Sep 30, 2011 409.43 Mn
Jun 30, 2011 96.72 Mn
Mar 31, 2011 306.09 Mn
Dec 31, 2010 302.05 Mn
Sep 30, 2010 306.43 Mn
Jun 30, 2010 97.92 Mn
Jun 30, 2009 100.88 Mn